Summary
The effects of bismuth nitrate pretreatment on the toxicity and antitumor activity ofcis-diamminedichloroplatinum (cisplatin, CDDP) were examined in nude mice that had been inoculated with human bladder-tumor tissue. Pretreatment with bismuth nitrate depressed the renal toxicity of CDDP without compromising its activity against a transplantable human bladder tumor. Renal metallothionein (MT) and bismuth (Bi) levels in nude mice were markedly increased by Bi preadministration, but no significant MT induction was observed in inoculated human bladder-tumor tissue in which only a trace amount of Bi was incorporated. Furthermore, it was confirmed that tumor platinum (Pt) concentrations in CDDP-treated mice were not affected by Bi pretreatment. Thus, the administration of Bi compounds prior to chemotherapy with CDDP may provide an effective mode of treatment for advanced bladder tumors.
Similar content being viewed by others
References
Baldew GS, Hamer CJ van den, Los G, Vermeulen NP, Goeij JJ de, McVie JG (1889) Selenium-induced protection againstcis-diamminedichloroplatinum(II) nephrotoxicity in mice and rats. Cancer Res 49: 3020
Borch RF, Katz JC, Lieder PH, Pleasants ME (1980) Effect of diethyldithiocarbamate resin on tumor response tocis-platinum in a rat model. Proc Natl Acad Sci USA 77: 5441
Brodie KG (1979) Analysis of arsenic and other trace elements by vapor generation. Am Lab 11: 58
Bühler RH, Kägi HR (1974) Human hepatic metallothioneins. FEBS Lett 39: 229
Corden BJ, Fine RL, Ozols RF, Collins M (1985) Clinical pharmacology of high-dose cisplatin. Cancer Chemother Pharmacol 14: 38
Earhart RH, Martin PA, Tutsch KD, Erturk E, Wheeler RH, Bull FE (1983) Improvement of the therapeutic index of cisplatin by pharmacologically induced chloruresis in the rat. Cancer Res 43: 1187
Endresen L, Bakka A, Rugstad HE (1983) Increased resistance to chlorambucil in cytoplasmic metallothionein. Cancer Res 43: 2918
Hiratsuka A, Kawashima K, Watabe T (1986) Detoxication of ultimate carcinogens by rat liver zinc-metallothionein (in Japanese). J Hyg Chem 32: 10
Howell SB, Pfeifle CE, Wung WE, Olshen RA (1983) Intraperitonealcis-diamminedichloroplatinum with systemic thiosulfate protection. Cancer Res 43: 1426
Kotsonis FN, Klaassen CD (1978) Comparison of methods for estimating hepatic metallothionein in rats. Toxicol Appl Pharmacol 42: 583
Koyama Y, Nakatogawa K, Naganuma A, Imura N, Onosaka S, Tamaka K (1984) Effect of metallothionein inducing metals on toxicity of inorganic mercury. Jpn J Hyg 39: 385
Leber PA, Miya TS (1976) A mechanism for cadmium- and zinc-induced tolerance to cadmium toxicity: involvement of metallothionein. Toxicol Appl Pharmacol 37: 403
Madias NE, Harrington JT (1978) Platinum nephrotoxicity. Am J Med 65: 307
Naganuma A, Satoh M, Yokoyama M, Imura N (1983) Selenium efficiently depressed toxic side effects ofcis-diamminedichloroplatinum. Res Commun Chem Pathol Pharmacol 42: 127
Naganuma A, Satoh M, Imura N (1984) Effect of selenite on renal toxicity and antitumor activity ofcis-diamminedichloroplatinum in mice inoculated with Ehrlich ascites tumor cells. J Pharmacobiocyn 7: 217
Naganuma A, Satoh M, Imura N (1987) Prevention of lethal and renal toxicity ofcis-diamminedichloroplatinum(II) by induction of metallothionein synthesis without compromising its antitumor activity in mice. Cancer Res 47: 983
Naganuma A, Satoh M, Imura N (1988) Specific reduction of toxic side-effects of Adriamycin by induction of metallothionein in mice. Jpn J Cancer Res 79: 406
Nakajima N (1979) Studies on heterotransplantation of human urogenital malignant neoplasms (in Japanese). Jpn J Urol 70: 849
Ovejera AA, Houchens DP, Barker AD (1978) Chemotherapy of human tumor xenografts in genetically athymic mice. Ann Clin Lab Sci 8: 50
Piotrowski JK, Bolanowska W, Sapata A (1973) Evaluation of metallothionein content in animal tissues. Acta Biochem Pol 20: 207
Satoh M, Naganuma A, Imura N (1988) Metallothionein induction prevents toxic side effects of cisplatin and Adriamycin used in combination. Cancer Chemother Pharmacol 21: 176
Satoh M, Naganuma A, Imura N (1988) Involvement of cardiac metallothionein in prevention of Adriamycin-induced lipid peroxidation in heart. Toxicology 53: 231
Satoh M, Miura N, Naganuma A, Matsuzaki N, Kawamura E, Imura N (1989) Prevention of adverse effects of γ-ray irradiation after metallothionein induction by bismuth subnitrate in mice. Eur J Cancer Clin Oncol 25: 1727
Satoh M, Naganuma A, Imura N (1989) Optimum schedule of selenium administration to reduce lethal and renal toxicities ofcis-diamminedichloroplatinum in mice. J Pharmcobiodyn 12: 246
Sharma RP, Edwards IR (1983)cis-Platinum: subcellular distribution and binding to cytosolic ligands. Biochem Pharmacol 32: 2665
Shiraishi N, Utsumi K, Morimoto S, Joja I, Iida S, Takeda Y, Aono K (1982) Inhibition of nitroblue tetrazolium reduction by metallothionein. Physiol Chem Phys 14: 533
Sternberg CN, Yagoda A, Scher HI, Watson RC, Ahmed T, Weiselberg LR, Geller N, Hollander PS, Herr HW, Sogani PC, Morse MJ, Witmore WF (1985) Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of urothelium. J Urol 133: 403
Sternberg JJ, Bracken RB, Handel PB, Johnson DE (1977) Combination chemotherapy (CISCA) for advanced urinary tract carcinoma: a preliminary report. JAMA 238: 2282
Szymanska JA, Mogilnicka EM, Kaszper BW (1977) Binding of bismuth in the kidneys of the rat: the role of metallothionein-like proteins. Biochem Pharmacol 26: 257
Thomas JP, Bachwoski GJ, Girotti AW (1986) Inhibition of cell membrane lipid peroxidation by cadmium- and zinc-metallothioneins. Biochim Biophys Acta 884: 448
Thornalley PJ, Vasak M (1985) Possible role for metallothionein in protection against radiation-induced oxidative stress. Kinetics and mechanism of its reaction with superoxide and hydrogen radicals. Biochim Biophys Acta 827: 26
Von Hoff DD, Schilsky R, Reichert CM, Reddick RL, Rosencweig M, Young RC, Muggia FM (1979) Toxic effects ofcis-dichlorodiammineplatinum(II) in man. Cancer Treat Rep 63: 1527
Webb M (1976) Protection by zinc against cadmium toxicity. Biochem Pharmacol 21: 2767
Williams SD, Donohue JP, Einhorn LH (1979) Advanced bladder cancer: therapy withcis-dichlorodiammineplatinum(II), Adriamycin, and 5-fluorouracil. Cancer Treat Rep 63: 1573
Yagoda A (1983) Chemotherapy for advanced urothelial cancer. Semin Urol 1: 60
Yagoda A, Watson RD, Gonzalez-Vitale JC, Grabstald H, Whitmore WF (1976)cis-Dichlorodiammineplatinum(II) in advanced bladder cancer. Cancer Treat Rep 60: 917
Yoshikawa H (1976) Tolerance to acute metal toxicity in mice having received a daily injection of its low dose. Ind Health 12: 175
Zelazowski AJ, Garvey JS, Hoeschele JD (1984) In vivo and in vitro binding of platinum to metallothionein. Arch Biochem Biophys 229: 246
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Kondo, Y., Satoh, M., Imura, N. et al. Effect of bismuth nitrate given in combination withcis-diamminedichloroplatinum(II) on the antitumor activity and renal toxicity of the latter in nude mice inoculated with human bladder tumor. Cancer Chemother. Pharmacol. 29, 19–23 (1991). https://doi.org/10.1007/BF00686330
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00686330